TY - JOUR
KW - cannabis
KW - Cannabis withdrawal
KW - Agonist replacement
KW - Nabiximols
KW - Marijuana
KW - study protocol
KW - Clinical Trial
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Female
KW - Adulthood (18 yrs & older)
KW - Young Adulthood (18-29 yrs)
KW - Thirties (30-39 yrs)
KW - Middle Age (40-64 yrs)
KW - Aged (65 yrs & older)
KW - Cannabinoids
KW - Drug Therapy
KW - Drug Withdrawal
KW - Substance use treatment
KW - article
KW - Australia
KW - 3383:Drug & Alcohol Rehabilitation
KW - New South Wales
KW - Double-Blind Method
KW - craving
KW - Humans
KW - Cannabidiol
KW - Male
KW - Treatment Outcome
KW - Cognition
KW - Combined Modality Therapy
KW - cognitive behavioral therapy
KW - Substance Withdrawal Syndrome
KW - Marijuana Abuse
KW - Randomized Controlled Trials as Topic
KW - Dronabinol
KW - Adult
KW - Drug Combinations
AU - Anjali K. Bhardwaj
AU - David J. Allsop
AU - Jan Copeland
AU - Iain S. McGregor
AU - Adrian Dunlop
AU - Marian Shanahan
AU - Raimondo Bruno
AU - Nghi Phung
AU - Mark Montebello
AU - Craig Sadler
AU - Jessica Gugusheff
AU - Melissa Jackson
AU - Jennifer Luksza
AU - Nicholas Lintzeris
A1 - 
AD - Discipline of Addiction Medicine, Central Clinical School, University of Sydney, Sydney, NSW, Australia anjali.bhardwaj@sydney.edu.au; School of Psychology, University of Sydney, Sydney, NSW, Australia ; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia ; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia ; Centre for Addiction Medicine, Cumberland Hospital, Western Sydney Local Health District, Sydney, NSW, Australia ; Langton Centre, Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, NSW, Australia ; Bhardwaj, Anjali K.,Sydney,Australia,School of Psychology, University of Sydney,anjali.bhardwaj@sydney.edu.au
BT - BMC Psychiatry
C5 - Financing & Sustainability; Opioids & Substance Use
DO - 10.1186/s12888-018-1682-2
JF - BMC Psychiatry
LA - English
M1 - Journal Article
PB - BioMed Central Limited
PY - 2018
SP - 14
T1 - Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: A study protocol
T2 - BMC Psychiatry
TI - Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: A study protocol
U1 - Financing & Sustainability; Opioids & Substance Use
U3 - 10.1186/s12888-018-1682-2
VL - 18
Y1 - 2018
Y2 - May 18
ER -